The Role of Metformin in the Management of NAFLD
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Its prevalence ranges 10–24% in the general population, reaching 60–95% and 28–55% in obese and diabetic patients, respectively. Although the etiology of NAFLD is still unclear, several lines of evidences have indi...
Main Authors: | Mazza, Angela, Fruci, Barbara, Garinis, Giorgia Anna, Giuliano, Stefania, Malaguarnera, Roberta, Belfiore, Antonino |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238361/ |
Similar Items
-
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
by: Fruci, Barbara, et al.
Published: (2013) -
The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
by: Malaguarnera, Roberta, et al.
Published: (2014) -
The Insulin Receptor: A New Target for Cancer Therapy
by: Malaguarnera, Roberta, et al.
Published: (2011) -
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
by: Malaguarnera, Roberta, et al.
Published: (2012) -
Current Management of NAFLD
by: MUNTEANU, MIHAI ALEXANDRU, et al.
Published: (2016)